Introduction
La Crosse encephalitis is a mosquito-borne encephalitis (inflammation of the brain) caused by the La Crosse virus.1 La Crosse virus is a member of the California serogroup of viruses.2 It is a relatively rare infection but can pose significant health risks, particularly among children and young adults. Understanding effective treatment options for La Crosse virus cases is important to lessen the severity of the disease and improve patient outcomes.
Transmission and symptoms of La Crosse virus
La Crosse virus, classified within the California serogroup of viruses, is primarily transmitted through the bite of infected mosquitoes, particularly Aedes triseriatus.3 La Crosse encephalitis is most commonly seen in the mid-Atlantic and midwestern areas of the United States. It's commonly found in wooded and rural places where there are lots of mosquitoes.
The virus generally remains among small animals like chipmunks and squirrels, which act as carriers.3 When people get bitten by infected mosquitoes, they can catch the virus, which can cause various symptoms. The majority of cases are asymptomatic and generally go undiagnosed.
La Crosse virus infections predominantly affect children and young adults, with the majority of cases reported during the summer and early autumn months, as this is when mosquito activity is at its peak.
Common symptoms typically include:4
Severe symptoms can include neurological complications such as:4
- Encephalitis (inflammation of the brain)
- Meningitis (infection of the protective membranes of the brain)
Diagnostic methods for La Crosse virus
Diagnostic methods for the La Crosse Virus involve different ways to identify and distinguish it from other illnesses. One important method is laboratory tests, where samples like blood or spinal fluid are checked for the virus's presence using techniques like ELISA (enzyme-linked immunosorbent assay) or PCR (polymerase chain reaction).1
Imaging techniques, like MRI (magnetic resonance imaging) or CT (computed tomography) scans, are also used to look for any brain or nerve problems, such as encephalitis or meningitis, caused by the virus.1,5
Lastly, doctors consider other illnesses that might have similar symptoms, such as other viruses or bacterial infections, to make sure they correctly diagnose the La Crosse virus. Combining these methods allows for better identification of the virus to ensure that the patient receives the best treatment.
Current treatment options
The main way to treat the La Crosse virus is by giving patients supportive care to help them feel better and recover. Unfortunately, there are currently no antiviral medicines that target this particular virus, therefore, any medicine is primarily aimed at alleviating symptoms.
Taking over-the-counter medications like acetaminophen (paracetamol) or ibuprofen can help reduce fever, ease headaches, and relieve pain. Resting and drinking plenty of fluids are also important for preventing dehydration, particularly if fever or vomiting occurs. This allows the body to recover and fight off the virus.
Doctors should keep a close eye on the patient’s symptoms, especially if they have any problems with their brain or nerves.5 This helps them catch any complications early and treat them quickly.
If a patient develops seizures, they can be given anti-seizure medication to control the appearance of seizures, which can be extended into long-term use if the patient develops epilepsy. If the symptoms are severe, there may be a need to be hospitalised to receive supportive care such as intravenous fluids, respiratory support, and brain or nerve monitoring.5
Emerging therapies and research
There is ongoing research to find new ways to treat and prevent La Crosse virus. Some of this research includes vaccination to help the body fight off the virus better, particularly for children and people living in high-risk areas.
A key branch of research on the La Crosse virus is the development of targeted therapies that directly target different parts of the virus.4 These targeted therapies are designed to attack only the virus while leaving the rest of the body unharmed.
In order to create these therapies, the way the virus works and interacts with our cells must first be studied. Targeted therapy would offer a more effective and precise way to treat the infection to help people recover faster.
Another key branch of exploration is through changing how our immune system responds to the virus.4 This includes supporting the immune system so that it can better recognise and attack the virus once it enters the body, along with preventing an excessive immune response that leads to inflammation and damage in the brain. This would reduce the severity of the symptoms and prevent neurological complications.
Prevention strategies
Because there are no current medications to treat this infection, prevention is currently the most effective method for preventing infection. As the disease is transmitted through mosquitoes, the most efficient way of prevention is to be aware of different ways to avoid them.7
Some of the best ways to avoid mosquitoes are:
Using insect repellent
Apply insect repellent containing DEET, picaridin, or lemon/eucalyptus oil before going outdoors. Lemon and eucalyptus oil should not be used on children under the age of 3.6,7
Wear protective clothing
Wear long-sleeved shirts, long pants, socks, and closed-toe shoes to minimise exposed skin.6
Use mosquito nets
Use mosquito nets or screens on windows and doors to prevent mosquitoes from entering your home.
Avoid outdoor activities during peak mosquito hours
Mosquitoes are most active during dawn and dusk, so try to limit outdoor activities during these times.
Remove standing water
Mosquitoes breed in stagnant water, so regularly emptying containers like flowerpots, buckets, and birdbaths can help reduce mosquitoes.
Use mosquito-repellent devices
Consider using mosquito-repellent devices such as coils or citronella candles outdoors.7
By taking these preventive measures, you can reduce your risk of mosquito bites and lower the likelihood of contracting the La Crosse virus.
Case studies and outcomes
Observing patients infected with the La Crosse virus has helped with understanding La Crosse encephalitis and the effect it has on the human body. Patients generally get better after rest, adequate hydration, and medicine for symptomatic relief. This highlights the importance of diagnosing the virus in the early stages of infection and acting quickly to help improve recovery.
However, some patients develop more serious symptoms in their brain or nervous system, such as encephalitis or meningitis. La Crosse virus can significantly affect people's lives, causing long-term problems and potential financial difficulties. How well patients react depends on age, overall health, and the speed at which they receive treatment.
FAQ’s
Where do most cases of La Crosse virus occur?
La Crosse encephalitis has been a public health issue in certain regions of the United States of America for several decades. The majority of La Crosse virus cases occur from upper-Midwestern, mid-Atlantic, and Southeastern states. As this species of mosquito is endemic (the area where the virus is commonly found) to the United States of America, you are unlikely to become infected with La Crosse virus if you live outside of this region.
How many cases of La Crosse virus occur each year?
The annual incidence of infections with the La Crosse virus is estimated to be approximately 10 to 30 cases per 100,000 people in areas where the virus is endemic.8 This rate varies depending on factors such as geographic location, mosquito activity levels, and the rate of mosquito breeding. In regions of the United States where the virus is more prevalent, there tend to be higher cases of La Crosse virus infections. However, it's important to note that many cases of La Crosse virus infection may go unreported or undiagnosed, so the true incidence may be higher than reported figures suggest.
Who is at risk of getting infected with La Crosse virus?
Although children are more likely to get infected with the virus, anyone who is in an area where the virus is found can become infected. You are more likely to get the La Crosse virus if you are frequently in a wooded area. For example, if you live, work, or spend significant time outdoors. Be sure to use preventative measures such as insect repellant and wear protective clothing if you are at high risk.8
How long does it take to develop symptoms after getting bitten by a mosquito?
Symptoms typically take between 5 to 15 days from the time of a bite with an infected mosquito. However, not everyone who is bitten by an infected mosquito will experience symptoms.
What do I do if I think that I, or somebody I know, might have La Crosse encephalitis?
If you suspect that you or somebody you know has La Crosse encephalitis, contact your healthcare providers for further support.
Summary
La Crosse virus, transmitted primarily by infected mosquitoes, poses a significant health risk, particularly among children and young adults. While there are no specific antiviral medications currently in use for the La Crosse virus, supportive care plays a crucial role in alleviating symptoms and aiding recovery. Treatment options include symptomatic relief with over-the-counter medications, ensuring adequate hydration and rest, and close monitoring of symptoms, especially neurological complications. In severe cases, hospitalisation may be necessary for intensive supportive care. Be sure to contact your healthcare provider if you are concerned that you have been infected with the La Crosse virus.
References
- Khan UM, Gudlavalleti A. La crosse encephalitis. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 [cited 2024 Feb 14]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK562248/.
- Hughes HR, Lanciotti RS, Blair CD, Lambert AJ. Full genomic characterization of California serogroup viruses, genus Orthobunyavirus, family Peribunyaviridae including phylogenetic relationships. Virology [Internet]. 2017 [cited 2024 Feb 16]; 512:201–10. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0042682217303331.
- Tsai TF. Arboviral infections in the United States. Infect Dis Clin North Am. 1991; 5(1):73–102.
- Harding S, Greig J, Mascarenhas M, Young I, Waddell LA. La Crosse virus: a scoping review of the global evidence. Epidemiol Infect [Internet]. 2019 [cited 2024 Feb 16]; 147:e66. Available from: https://www.cambridge.org/core/product/identifier/S0950268818003096/type/journal_article.
- Teleron ALA, Rose BK, Williams DM, Kemper SE, McJunkin JE. La Crosse Encephalitis: An Adult Case Series. The American Journal of Medicine [Internet]. 2016 [cited 2024 Feb 16]; 129(8):881–4. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0002934316303497.
- Vahey GM, Lindsey NP, Staples JE, Hills SL. La Crosse Virus Disease in the United States, 2003–2019. The American Journal of Tropical Medicine and Hygiene [Internet]. 2021 [cited 2024 Feb 16]; 105(3):807–12. Available from: https://www.ajtmh.org/view/journals/tpmd/105/3/article-p807.xml.
- American Academy of Pediatrics., Pickering LK. 2000 Red book: report of the Committee on Infectious Diseases. 25th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2000.
- McJunkin JE, Khan RR, Tsai TF. CALIFORNIA–LA CROSSE ENCEPHALITIS. Infectious Disease Clinics of North America [Internet]. 1998 [cited 2024 Feb 16]; 12(1):83–93. Available from: https://www.sciencedirect.com/science/article/pii/S0891552005704104.

